FDA Archives

Beyond Weight Loss: A New Era for GLP-1s and Heart Health

A landmark clinical trial has revealed that the GLP-1 medication semaglutide significantly reduces the risk of…

While known for weight management, a landmark clinical trial has revealed a significant new role for…

Beyond weight management, the FDA has now approved a leading GLP-1 medication to actively reduce the…

A landmark clinical trial reveals that semaglutide (Wegovy) significantly reduces the risk of heart attack and…

New research reveals GLP-1 agonists like semaglutide do more than aid weight loss. A landmark study…

Recent landmark research is reframing the conversation around GLP-1 medications. A major clinical trial and a…

New research reveals GLP-1 agonist medications may significantly reduce cardiovascular events like heart attacks and strokes…

New research and a landmark FDA approval are reframing GLP-1 medications like semaglutide. A major clinical…

Beyond weight management, a landmark clinical trial has confirmed that GLP-1 agonists like semaglutide can significantly…

Recent landmark research reveals that GLP-1 agonist medications do more than aid weight management. A major…